secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0000950170-25-006819
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo receives Nasdaq delisting notice for bid price non-compliance; intends to appeal with reverse split plan
--------------------------------------------------------------------------------

- Nasdaq notified Organovo on Jan 16, 2025 that it failed to regain compliance with $1 minimum bid price rule.
- Company is not eligible for a second 180-day compliance period on The Nasdaq Capital Market.
- Organovo intends to timely request a hearing, which will automatically stay any delisting pending a decision.
- Hearing panel may grant an extension up to July 15, 2025; company plans to propose a reverse stock split.
- Common stock continues to trade on Nasdaq under symbol ONVO pending the hearing outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025006819/0000950170-25-006819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025006819/onvo-20250116.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-006819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer